As of 2025-07-04, the Fair Value of Gene Biotherapeutics Inc (CRXM) is -0.20 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 USD, the upside of Gene Biotherapeutics Inc is -19,940,425.00%.
With the market price of 0.00 USD and our fair value calculation, Gene Biotherapeutics Inc (CRXM) is not a good investment. Investing in CRXM stocks now will result in a potential loss of 19,940,425.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 5Y Avg | |
| Net income | -2.92 | -1.89 | -0.43 | 0.87 | -0.52 | -0.98 |
| YoY growth | 21.08% | 35.09% | 77.04% | 299.29% | -159.76% | 54.55% |
| Market Cap (mil) | 0.00 |
| P/E | |
| Forward P/E |
| EPS | -0.01 |
| Avg earnings growth rate | 54.55% |
| TTM earnings | -0.52 |